치료경험이 없는 환자들의 객관적 반응률은 20%, 중앙 생존 기간은 28.6개월로 1차 치료의 가능성을 보여 주었다.
Even in patients with no treatment experience, the objective response rate was 20%, and the central survival period was 28.6 months, showing the potential as a primary treatment.